VisCardia is investigating¬†a novel therapy for improving hemodynamic function to manage¬†medical refractory heart failure. Our proprietary therapy uses the patient’s own thoracic musculature to improve cardiac filling and output, and relieve symptoms resulting from¬†hemodynamic insuffciency.